NCT06571981 Conventional Ultrasound Versus Remote Ultraportable ulTrasound in the Context of Viral Hepatitis
| NCT ID | NCT06571981 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Naik Vietti Violi |
| Condition | Hepatitis |
| Study Type | OBSERVATIONAL |
| Enrollment | 102 participants |
| Start Date | 2024-11-01 |
| Primary Completion | 2026-09-30 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 102 participants in total. It began in 2024-11-01 with a primary completion date of 2026-09-30.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Comparison of abdominal US exam in patients with viral hepatitis between ultraportable US with teleradiology capacities (TUP) versus conventional ultrasound (CUS)
Eligibility Criteria
Inclusion Criteria: * Informed Consent signed by the subject * All adult patients with viral hepatitis for which an ultrasound is planned Exclusion Criteria: * Known or suspected non-compliance * Inability to follow the procedures of the study, e.g. due to language problems, psychological disorders, dementia, etc. of the participant, * Previous enrollment into the current study
Contact & Investigator
Naïk Vietti Violi, MD
STUDY DIRECTOR
CHUV-UNIL
Frequently Asked Questions
Who can join the NCT06571981 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hepatitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06571981 currently recruiting?
Yes, NCT06571981 is actively recruiting participants. Contact the research team at naik.vietti-violi@chuv.ch for enrollment information.
Where is the NCT06571981 trial being conducted?
This trial is being conducted at Lausanne, Switzerland.
Who is sponsoring the NCT06571981 clinical trial?
NCT06571981 is sponsored by Naik Vietti Violi. The principal investigator is Naïk Vietti Violi, MD at CHUV-UNIL. The trial plans to enroll 102 participants.